JP2009511080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009511080A5 JP2009511080A5 JP2008536626A JP2008536626A JP2009511080A5 JP 2009511080 A5 JP2009511080 A5 JP 2009511080A5 JP 2008536626 A JP2008536626 A JP 2008536626A JP 2008536626 A JP2008536626 A JP 2008536626A JP 2009511080 A5 JP2009511080 A5 JP 2009511080A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- isolated
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 47
- 102000039446 nucleic acids Human genes 0.000 claims 26
- 108020004707 nucleic acids Proteins 0.000 claims 26
- 150000007523 nucleic acids Chemical class 0.000 claims 26
- 239000012634 fragment Substances 0.000 claims 25
- 150000001413 amino acids Chemical group 0.000 claims 23
- 241000712461 unidentified influenza virus Species 0.000 claims 23
- 241000282465 Canis Species 0.000 claims 16
- 230000028993 immune response Effects 0.000 claims 14
- 241000282472 Canis lupus familiaris Species 0.000 claims 12
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 7
- 101710154606 Hemagglutinin Proteins 0.000 claims 7
- 102000005348 Neuraminidase Human genes 0.000 claims 7
- 108010006232 Neuraminidase Proteins 0.000 claims 7
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 7
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 7
- 101710176177 Protein A56 Proteins 0.000 claims 7
- 239000000185 hemagglutinin Substances 0.000 claims 7
- 101710128560 Initiator protein NS1 Proteins 0.000 claims 5
- 101710144127 Non-structural protein 1 Proteins 0.000 claims 5
- 108010061100 Nucleoproteins Proteins 0.000 claims 5
- 102000011931 Nucleoproteins Human genes 0.000 claims 5
- 230000001939 inductive effect Effects 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 230000002238 attenuated effect Effects 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72780805P | 2005-10-18 | 2005-10-18 | |
| US60/727,808 | 2005-10-18 | ||
| US11/539,123 | 2006-10-05 | ||
| US11/539,123 US7468187B2 (en) | 2005-10-18 | 2006-10-05 | Canine influenza virus and related compositions and methods of use |
| PCT/US2006/060025 WO2007048086A2 (en) | 2005-10-18 | 2006-10-17 | Canine influenza virus and related compositions and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009511080A JP2009511080A (ja) | 2009-03-19 |
| JP2009511080A5 true JP2009511080A5 (enExample) | 2009-11-26 |
| JP5042230B2 JP5042230B2 (ja) | 2012-10-03 |
Family
ID=37906978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536626A Active JP5042230B2 (ja) | 2005-10-18 | 2006-10-17 | イヌインフルエンザウイルスならびに関連組成物および使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US7468187B2 (enExample) |
| EP (1) | EP1933866B1 (enExample) |
| JP (1) | JP5042230B2 (enExample) |
| KR (1) | KR101412897B1 (enExample) |
| AR (1) | AR056133A1 (enExample) |
| AT (1) | ATE491468T1 (enExample) |
| AU (1) | AU2006304895B2 (enExample) |
| CA (1) | CA2626452C (enExample) |
| DE (1) | DE602006018970D1 (enExample) |
| NO (1) | NO342145B1 (enExample) |
| NZ (1) | NZ567017A (enExample) |
| RS (1) | RS53723B1 (enExample) |
| RU (1) | RU2410427C2 (enExample) |
| WO (1) | WO2007048086A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| EP2489739B1 (en) * | 2005-04-21 | 2019-11-20 | University of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| NZ566490A (en) * | 2005-10-07 | 2011-06-30 | Pfizer Prod Inc | Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza |
| AU2013205112C1 (en) * | 2005-10-19 | 2015-12-03 | Cornell Research Foundation, Inc. | Influenza viruses able to infect canids, uses thereof |
| WO2007047728A2 (en) * | 2005-10-20 | 2007-04-26 | Wyeth | Compositions and methods for the treatment of canine influenza virus disease |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| US7674469B2 (en) | 2006-10-25 | 2010-03-09 | Internet International B.V. | Feline influenza vaccine and method of use |
| PT2670432T (pt) | 2011-02-04 | 2021-05-04 | Zoetis Services Llc | Composições imunogénicas de bordetella bronchiseptica |
| CN103596588B (zh) | 2011-02-04 | 2016-02-03 | 佐蒂斯有限责任公司 | 用于犬呼吸道疾病综合征的组合物 |
| BR112013023354B1 (pt) | 2011-03-14 | 2022-02-15 | Boehringer Ingelheim Animal Health Usa Inc | Composição imunogênica compreendendo cepas de vírus da rinite equina a (erav) e seu método de produção |
| KR101484588B1 (ko) * | 2012-10-24 | 2015-01-20 | 대한민국 | 개 인플루엔자 ｖｌｐ 백신의 제조방법 |
| US10080792B2 (en) | 2013-09-23 | 2018-09-25 | Engen Bio, Inc. | Influenza vaccine and therapy |
| CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
| AU2019302562B2 (en) * | 2018-07-10 | 2026-02-19 | Seqirus Pty Ltd | Removal of agglomerates |
| JP7340290B2 (ja) * | 2021-05-21 | 2023-09-07 | 大輔 島岡 | 抗エンベロープウイルス中性洗浄剤、消毒剤組成物、及びエンベロープウイルスの不活性化方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4009258A (en) * | 1972-09-25 | 1977-02-22 | The Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same |
| GB1488800A (en) * | 1973-11-29 | 1977-10-12 | Wellcome Found | Influenza vaccines |
| US4140762A (en) * | 1974-01-14 | 1979-02-20 | Sandoz Ltd. | Influenza sub-unit vaccine |
| US4029763A (en) * | 1974-08-05 | 1977-06-14 | Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
| US4318903A (en) * | 1978-07-12 | 1982-03-09 | Smithkline-Rit | Live influenza virus vaccine and the preparation thereof |
| US4278662A (en) * | 1979-10-16 | 1981-07-14 | Smith Kline - Rit | Attenuated influenza type A virus vaccine |
| US4338296A (en) * | 1979-10-16 | 1982-07-06 | Smithkline-Rit | Influenza virus and process of producing a vaccine therefrom |
| GB8300467D0 (en) * | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
| JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
| GB8703696D0 (en) * | 1987-02-18 | 1987-03-25 | Oxford J S | Influenza vaccine |
| US5136019A (en) * | 1989-05-24 | 1992-08-04 | Sri International | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| US5741493A (en) * | 1991-01-24 | 1998-04-21 | Pasteur Merieux Serums Et Vaccins | Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive |
| JPH06508623A (ja) * | 1991-06-19 | 1994-09-29 | エス・アール・アイ・インターナシヨナル | 抗ウィルス剤としてのインフルエンザウィルスのｍ−蛋白質ペプチド |
| US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| ES2370937T3 (es) * | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| PT733113E (pt) * | 1994-01-11 | 2007-08-10 | Vlaams Interuniv Inst Biotech | Vacina contra a gripe |
| US6482414B1 (en) | 1998-08-13 | 2002-11-19 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
| US6177082B1 (en) * | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
| IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| EP2489739B1 (en) | 2005-04-21 | 2019-11-20 | University of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7384642B2 (en) * | 2005-08-25 | 2008-06-10 | Merial Limited | Canine influenza vaccines |
| NZ566490A (en) * | 2005-10-07 | 2011-06-30 | Pfizer Prod Inc | Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza |
-
2006
- 2006-10-05 US US11/539,123 patent/US7468187B2/en active Active
- 2006-10-17 AT AT06827896T patent/ATE491468T1/de not_active IP Right Cessation
- 2006-10-17 AU AU2006304895A patent/AU2006304895B2/en active Active
- 2006-10-17 RU RU2008119438/10A patent/RU2410427C2/ru active
- 2006-10-17 EP EP06827896A patent/EP1933866B1/en active Active
- 2006-10-17 NZ NZ567017A patent/NZ567017A/en unknown
- 2006-10-17 WO PCT/US2006/060025 patent/WO2007048086A2/en not_active Ceased
- 2006-10-17 RS RS20080174A patent/RS53723B1/sr unknown
- 2006-10-17 JP JP2008536626A patent/JP5042230B2/ja active Active
- 2006-10-17 DE DE602006018970T patent/DE602006018970D1/de active Active
- 2006-10-17 KR KR1020087008658A patent/KR101412897B1/ko active Active
- 2006-10-17 CA CA2626452A patent/CA2626452C/en active Active
- 2006-10-17 AR ARP060104532A patent/AR056133A1/es not_active Application Discontinuation
-
2008
- 2008-05-07 NO NO20082149A patent/NO342145B1/no unknown
- 2008-09-15 US US12/210,837 patent/US7842295B2/en not_active Ceased
-
2012
- 2012-11-29 US US13/688,990 patent/USRE44916E1/en active Active
-
2013
- 2013-11-08 US US14/075,618 patent/USRE45564E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mozdzanowska et al. | Th cell-deficient mice control influenza virus infection more effectively than Th-and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance | |
| JP6352974B2 (ja) | ワクチンのための高力価組み換えインフルエンザ・ウィルス | |
| Rajao et al. | Swine as a model for influenza A virus infection and immunity | |
| CA2631812C (en) | Chimeric viruses presenting non-native surface proteins and uses thereof | |
| O’Donnell et al. | The contribution of animal models to the understanding of the host range and virulence of influenza A viruses | |
| Whittaker | Intracellular trafficking of influenza virus: clinical implications for molecular medicine | |
| Kaverin et al. | Intergenic HA–NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes | |
| JP2015119730A5 (enExample) | ||
| CN101952427A (zh) | 产生流感病毒粒子的线性表达构建体 | |
| Choi et al. | Genetic relationship of H3 subtype avian influenza viruses isolated from domestic ducks and wild birds in Korea and their pathogenic potential in chickens and ducks | |
| NO20082149L (no) | Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for bruk | |
| WO2013030176A2 (en) | Live attenuated influenza virus | |
| Yassine et al. | Interspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factors | |
| WO2018013704A1 (en) | Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same | |
| CN102443571A (zh) | 一株鸡源h9n2禽流感病毒毒株及其应用 | |
| Su et al. | Emergence and pandemic potential of avian influenza a (H7N9) virus | |
| CA2880409A1 (en) | Production of infectious influenza viruses | |
| KR102091281B1 (ko) | 재조합 인플루엔자 a 바이러스 h5n6주 및 이를 포함하는 고병원성 인플루엔자 a 바이러스 백신 조성물 | |
| US7527798B2 (en) | Composition and method for preventing or treating a virus infection | |
| Rott | The role of the hemagglutinin in infectivity and pathogenicity of avian influenza viruses | |
| US7354589B2 (en) | Multiple antigenic agents and methods for using the same | |
| JP2005170945A (ja) | インフルエンザ血球凝集素多価ワクチンの製造方法 | |
| US7740860B2 (en) | Composition and method for preventing or treating a virus infection | |
| CN107151659B (zh) | 一种流感病毒株及其应用 | |
| CN102234636B (zh) | 重组甲型H1N1流感病毒冷适应弱毒活疫苗株(SC/AAca)的制备及应用 |